D. Carr

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.

E. Bow, M. Laverdière, C. Rotstein, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.

E. Bow, R. Roberts, M. Laverdière, 2000, The Journal of antimicrobial chemotherapy.

Non‐hodgkin's lymphomas in patients with human immunodeficiency virus infection. Presence of epstein–barr virus by In situ hybridization, clinical presentation, and follow‐up

J. Guarner, E. Unger, J. Eley, 1991, Cancer.

Randomized Placebo-Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy

E. Bow, M. Laverdière, C. Rotstein, 1999 .

Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000.

D. Weiss, D. Weiss, M. Phillips, 2001, Emerging infectious diseases.

Prophylaxis of fever and infection in adult cancer patients. A placebo‐controlled trial of oral trimethoprim‐sulfamethoxazole plus erythromycin

B. Kramer, K. Rand, P. Pizzo, 1984, Cancer.

Antimicrobial regimens prescribed by Canadian physicians for chemotherapy-induced febrile neutropenic episodes.

E. Bow, M. Laverdière, C. Rotstein, 1999, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.